Mesalamine Capsule, Delayed Release
Product Images NDC 60687-556

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 60687-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp55632

FDA Label Image

400 mg Mesalamine Dr Capsule Blister (Blister)

400 mg Mesalamine Dr Capsule Blister (Blister)
This is a set of labels for mesalamine delayed-release capsules of 400 mg strength, packed by American Health Packaging, Columbus, OH with different LOT numbers and EXPIRY dates.*
FDA Label Image

Carton

Carton
This is a package of Mesalamine Delayed-Release Capsules, each containing four 100mg tablets of mesalamine. The package includes 20 capsules, which cannot be crushed or chewed and should be swallowed whole. It can be taken with or without food and should be stored between 15°C to 30°C. This drug should be kept out of reach of children and not be used if the blister is torn or broken. The package is distributed by American Health Packaging in Ohio.*
FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.